Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter Randomized Trial of Deferred Cytoreductive Nephrectomy in Synchronous Metastatic Renal Cell Carcinoma Receiving Checkpoint Inhibitors: a Trial Evaluating the Impact of Surgery or No Surgery. The NORDIC-SUN-Trial

NCT03977571 is registered in ClinicalTrials.gov with Niels Fristrup as lead sponsor.

NCT NCT03977571
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03977571 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter Randomized Trial of Deferred Cytoreductive Nephrectomy in Synchronous Metastatic Renal Cell Carcinoma Receiving Checkpoint Inhibitors: a Trial Evaluating the Impact of Surgery or No Surgery. The NORDIC-SUN-Trial
Lead sponsor
Niels Fristrup
Phase
Not applicable
Overall status
Recruiting
Start date
July 6, 2020
Completion date
December 1, 2031
Enrollment
400 (estimated)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

kidney cancer, renal cell carcinoma metastatic, synchronous neoplasm